{
    "2019-10-27": [
        [
            {
                "time": "",
                "original_text": "【中信建投医药|行业周报】基金三季度持仓：重点领域龙头获得青睐",
                "features": {
                    "keywords": [
                        "基金",
                        "三季度",
                        "持仓",
                        "重点领域",
                        "龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "公募基金2019Q3医药持仓分析【兴证医药】",
                "features": {
                    "keywords": [
                        "公募基金",
                        "2019Q3",
                        "医药",
                        "持仓",
                        "分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}